In vitro activity of tedizolid against Staphylococcus aureus and Streptococcus pneumoniae collected in 2013 and 2014 from sites in Latin American countries, Australia, New Zealand, and China
Crossref DOI link: https://doi.org/10.1007/s10096-016-2744-3
Published Online: 2016-09-27
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Biedenbach, D. J.
Bouchillon, S. K.
Johnson, B.
Alder, J.
Sahm, D. F.
Funding for this research was provided by:
Bayer HealthCare
License valid from 2016-09-27